Table of Content


Introduction
Community Acquired Pneumonia - Overview
Community Acquired Pneumonia - Therapeutics Development
Community Acquired Pneumonia - Therapeutics Assessment
Community Acquired Pneumonia - Companies Involved in Therapeutics Development
Community Acquired Pneumonia - Drug Profiles
Community Acquired Pneumonia - Dormant Projects
Community Acquired Pneumonia - Discontinued Products
Community Acquired Pneumonia - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Community Acquired Pneumonia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Community Acquired Pneumonia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Community Acquired Pneumonia - Pipeline by Basilea Pharmaceutica Ltd, H2 2020
Community Acquired Pneumonia - Pipeline by Beijing Fogangren Bio-Pharm Tech Co Ltd, H2 2020
Community Acquired Pneumonia - Pipeline by BioAegis Therapeutics Inc, H2 2020
Community Acquired Pneumonia - Pipeline by Biotest AG, H2 2020
Community Acquired Pneumonia - Pipeline by Combioxin SA, H2 2020
Community Acquired Pneumonia - Pipeline by InflaRx NV, H2 2020
Community Acquired Pneumonia - Pipeline by ioGenetics Inc, H2 2020
Community Acquired Pneumonia - Pipeline by Iterum Therapeutics Plc, H2 2020
Community Acquired Pneumonia - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2020
Community Acquired Pneumonia - Pipeline by La Jolla Pharmaceutical Company, H2 2020
Community Acquired Pneumonia - Pipeline by Meiji Seika Pharma Co Ltd, H2 2020
Community Acquired Pneumonia - Pipeline by Merck & Co Inc, H2 2020
Community Acquired Pneumonia - Pipeline by Nabriva Therapeutics Plc, H2 2020
Community Acquired Pneumonia - Pipeline by Paratek Pharmaceuticals Inc, H2 2020
Community Acquired Pneumonia - Pipeline by ProThera Biologics Inc, H2 2020
Community Acquired Pneumonia - Pipeline by TaiGen Biotechnology Co Ltd, H2 2020
Community Acquired Pneumonia - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2020
Community Acquired Pneumonia - Pipeline by Wockhardt Ltd, H2 2020
Community Acquired Pneumonia - Dormant Projects, H2 2020
Community Acquired Pneumonia - Dormant Projects, H2 2020 (Contd..1), H2 2020
Community Acquired Pneumonia - Discontinued Products, H2 2020